RESUMEN
BACKGROUND: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide actionable targets to improve adherence and outcomes. METHODS: Ninety-nine alopecia patients at an outpatient university dermatology specialty clinic completed a survey assessing demographics and aspects of treatment adherence. Patients currently using minoxidil additionally completed a survey grading their level of adherence. A two-sample t-test was used to compare the average age between adherent and non-adherent groups. Differences in demographics and patient factors by adherence level were evaluated using the 2-tailed χ2 test and Fisher's exact test. RESULTS: Adherent patients had been using topical minoxidil for a median of 24 months when surveyed; non-adherent patients used the medication for a median of 3.5 months prior to discontinuation. A larger portion of non-adherent patients used minoxidil for fewer than 3 months (35%) compared to adherent patients (3%), P<.001. The most common reason non-adherent patients discontinued therapy was no improvement (50%). DISCUSSION/CONCLUSION: Non-adherent patients were less likely to use topical minoxidil for at least 3 months and often cited lack of improvement as a reason for discontinuing. Patient education and intervention prior to the 3-month mark may help improve adherence. J Drugs Dermatol. 2023;22(3): doi:10.36849/JDD.6639.
Asunto(s)
Alopecia , Minoxidil , Humanos , Alopecia/diagnóstico , Alopecia/tratamiento farmacológico , Cooperación del Paciente , Grupo SocialRESUMEN
Hereditary transthyretin amyloidosis is a multisystemic autosomal dominant genetic disorder characterized by progressive distal sensory-motor polyneuropathy or restrictive cardiomyopathy, secondary to amyloid deposits. Its pathogenesis lies in the TTR gene mutation, and the Val50Met mutation is the most frequent. Patients have significant differences in the onset and severity of clinical presentation according to their country of origin. The diagnosis of this pathology is complex, even more in countries where it is not considered endemic. However, early suspicion and management are essential to improve survival and avoid unnecessary diagnostic and therapeutic strategies. We report a 69-year-old woman who presented a sensory-motor polyneuropathy, predominantly sensory, associated with distal neuropathic pain and bilateral vitritis. The history of her Italian father with polyneuropathy of unspecified etiology stood out. A vitreous biopsy identified amyloid substance deposits (congo red positive). These were also confirmed on a superficial peroneal nerve biopsy. During the etiological study of her polyneuropathy, an increased Kappa/Lambda index of 2.55 mg/L stood out. Therefore, light chain amyloidosis was suspected, and chemotherapy treatment was indicated without favorable response. After 10 years of progressive neurological and ophthalmological involvement, a genetic study confirmed the first case of late-onset hereditary transthyretin amyloidosis Val50Met with polyneuropathy in Chile.
Asunto(s)
Neuropatías Amiloides Familiares , Polineuropatías , Humanos , Femenino , Anciano , Prealbúmina/genética , Neuropatías Amiloides Familiares/complicaciones , Neuropatías Amiloides Familiares/diagnóstico , Neuropatías Amiloides Familiares/genética , Mutación , Polineuropatías/etiología , Polineuropatías/genéticaRESUMEN
BACKGROUND: Immunoglobulin light chain (AL) amyloidosis is a rare and underdiagnosed entity. AIM: To characterize patients with AL amyloidosis in Chilean public health centers. MATERIAL AND METHODS: We conducted a retrospective, multicenter study. Public centers of the Chilean Monoclonal Gammopathies Cooperative Group were asked to search for patients with AL amyloidosis in their databases. Epidemiological, clinical and laboratory characteristics were evaluated. RESULTS: Forty-two patients aged 22 to 84 years were found. Twenty four percent had localized AL amyloidosis; 64% had a lambda light chain clone; 47% were associated with multiple myeloma and 9% with non-Hodgkin lymphoma. The most commonly involved organ was the kidney (76%). Serum free light chains were measured in 31% and an echocardiogram was performed in 74% of patients. Seventeen percent of patients received only palliative care, 17% were treated with bortezomib, 21% with thalidomide, and 40% with melphalan. No patient was transplanted. The mean overall survival (OS) of the group was 19 months. The 5-year OS was 28%. CONCLUSIONS: It is important to obtain these realistic, national data to initiate strategies to improve early diagnosis and proper management of this disease.
Asunto(s)
Servicios de Salud/estadística & datos numéricos , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/epidemiología , Sector Público/estadística & datos numéricos , Adulto , Anciano , Anciano de 80 o más Años , Electroforesis de las Proteínas Sanguíneas , Chile/epidemiología , Femenino , Humanos , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/fisiopatología , Cadenas lambda de Inmunoglobulina , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Tiempo , Adulto JovenAsunto(s)
Alopecia , Liquen Plano , Alopecia/epidemiología , Fibrosis , Hormonas Esteroides Gonadales , Humanos , Masculino , Estudios RetrospectivosRESUMEN
The face has not been considered a common site of fixed drug eruption, and the authors lack dermatoscopic studies of this condition on the subject. The authors sought to characterize clinical and dermatoscopic features of 8 cases of an eruptive facial postinflammatory lentigo. The authors conducted a retrospective review of 8 cases with similar clinical and dermatoscopic findings seen from 2 medical centers in 2 countries during 2010-2014. A total of 8 patients (2 males and 6 females) with ages that ranged from 34 to 62 years (mean: 48) presented an abrupt onset of a single facial brown-pink macule, generally asymmetrical, with an average size of 1.9 cm. after ingestion of a nonsteroidal antiinflammatory drugs that lasted for several months. Dermatoscopy mainly showed a pseudonetwork or uniform areas of brown pigmentation, brown or blue-gray dots, red dots and/or telangiectatic vessels. In the epidermis, histopathology showed a mild hydropic degeneration and focal melanin hyperpigmentation. Melanin can be found freely in the dermis or laden in macrophages along with a mild perivascular mononuclear infiltrate. The authors describe eruptive facial postinflammatory lentigo as a new variant of a fixed drug eruption on the face.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Dermoscopía , Erupciones por Medicamentos/patología , Dermatosis Facial/patología , Lentigo/patología , Piel/patología , Adulto , Biomarcadores/análisis , Biopsia , Chile , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/metabolismo , Dermatosis Facial/inducido químicamente , Dermatosis Facial/metabolismo , Femenino , Humanos , Hiperpigmentación/inducido químicamente , Hiperpigmentación/patología , Lentigo/inducido químicamente , Lentigo/metabolismo , Masculino , Melaninas/análisis , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Piel/química , Piel/efectos de los fármacos , EspañaRESUMEN
The scalp microbiome represents an array of microorganisms important in maintaining scalp homeostasis and mediating inflammation. Scalp microbial dysregulation has been implicated in dermatologic conditions including alopecia areata (AA), dandruff/seborrheic dermatitis (D/SD), scalp psoriasis (SP) and folliculitis decalvans (FD). Understanding the impact of scalp microbial dysbiosis gives insight on disease pathophysiology and guides therapeutic decision making. Herein we review the scalp microbiome and its functional role in scalp conditions by analysis of metagenomic medical literature in alopecia, D/SD, SP, and other dermatologic disease.Increased abundance of Malassezia, Staphylococcus, and Brevibacterium was associated with SD compared to healthy controls. A higher proportion of Corynebacterium, actinobacteria, and firmicutes are present in AA patients, and lower proportions of Staphylococcus caprae are associated with worse clinical outcomes. Decreased prevalence of actinobacteria and Propionibacterium and increased firmicutes, staphylococcus, and streptococcus are associated with scalp psoriasis. Studies of central centrifugal cicatricial alopecia (CCCA) suggest scalp microbial composition contributes to CCCA's pro-inflammatory status. The most common organisms associated with FD include methicillin-resistant S. aureus and S. lugdunensis. Antifungals have been a mainstay treatment for these diseases, while other alternatives including coconut oils and shampoos with heat-killed probiotics have shown considerable potential efficacy by replenishing the scalp microbiome.
Asunto(s)
Microbiota , Cuero Cabelludo , Humanos , Microbiota/efectos de los fármacos , Microbiota/inmunología , Cuero Cabelludo/microbiología , Dermatosis del Cuero Cabelludo/microbiología , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Dermatosis del Cuero Cabelludo/terapia , Disbiosis/microbiología , Disbiosis/inmunología , Foliculitis/microbiología , Foliculitis/diagnóstico , Foliculitis/tratamiento farmacológico , Foliculitis/terapia , Psoriasis/microbiología , Psoriasis/tratamiento farmacológico , Psoriasis/inmunología , Psoriasis/terapia , Dermatitis Seborreica/microbiología , Dermatitis Seborreica/tratamiento farmacológico , Dermatitis Seborreica/terapia , Alopecia Areata/microbiología , Alopecia Areata/inmunología , Alopecia Areata/terapia , Alopecia Areata/tratamiento farmacológico , Caspa/microbiología , Caspa/tratamiento farmacológicoRESUMEN
Alopecia areata (AA) is managed with prolonged medical treatments and cosmetic therapies, whose cost can be burdensome. We sought to identify the costs of AA treatment and consolidate the available data for the practicing dermatologist by performing a PubMed search of articles indexed for MEDLINE. Ten studies including approximately 16,000 patients with AA across a range of Oxford Centre for Evidence-Based Medicine Levels of Evidence were included. Studies showed that despite the limited efficacy of many AA therapies, patients incurred substantial expenses to manage their AA.
Asunto(s)
Alopecia Areata , Costo de Enfermedad , Alopecia Areata/economía , Alopecia Areata/terapia , Alopecia Areata/tratamiento farmacológico , Humanos , Costos de la Atención en Salud/estadística & datos numéricos , Dermatólogos/economía , Fármacos Dermatológicos/economía , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/uso terapéuticoRESUMEN
Hair disorders, including central centrifugal cicatricial alopecia (CCCA), traction alopecia (TA), and acquired trichorrhexis nodosa (ATN), commonly occur in individuals with curly textured hair. Curly textured hair in individuals of African descent has unique properties and can present diagnostic and therapeutic challenges. CCCA has been linked to uterine leiomyoma and type 2 diabetes mellitus, as well as fibroproliferation. TA often presents with a fringe sign and can arise from high-tension hairstyles presumed to be protective. Trichoscopy is useful in establishing a diagnosis; perifollicular halos are more commonly seen than perifollicular erythema or scale in CCCA. In TA, miniaturized follicles, hair casts, and "flambeau sign" can be seen. Hairstyling practices likely contribute to TA and ATN; however, the data are mixed on the role of chemical relaxers and heat styling in CCCA. Unique considerations in the presentation of frontal fibrosing alopecia in curly textured hair have also been published recently. This review provides a comprehensive, up-to-date summary of these disorders with an emphasis on their unique properties, as well as considerations in hair care for curly textured hair.
Asunto(s)
Alopecia , Cabello , Humanos , Alopecia/diagnóstico , Alopecia/etiología , Alopecia/patología , Cabello/patología , Folículo Piloso/patología , Preparaciones para el Cabello/efectos adversos , Dermoscopía , Enfermedades del Cabello/diagnóstico , Enfermedades del Cabello/patología , Enfermedades del Cabello/etiología , Cicatriz/etiología , Cicatriz/patología , Cicatriz/diagnóstico , FemeninoRESUMEN
African hair shaft and pigmented scalp have unique features that challenge diagnosis in scarring alopecia. In addition, Black patients may associate 2 or more types of hair disorders. Therefore, it is imperative to understand their findings thoroughly to establish a good diagnosis. Differential diagnosis on the frontal scalp includes traction alopecia and frontal fibrosing alopecia. Disorders such as central centrifugal cicatricial alopecia, fibrosing alopecia in a pattern distribution, discoid lupus erythematosus, and lichen planopilaris usually affect the middle scalp. Folliculitis decalvans, dissecting cellulitis, and acne keloidalis nuchae are the main differential diagnosis of the posterior scalp.
Asunto(s)
Cicatriz , Lupus Eritematoso Discoide , Humanos , Cicatriz/etiología , Alopecia/diagnóstico , Alopecia/etiología , Cabello , Cuero Cabelludo , Lupus Eritematoso Discoide/complicaciones , Lupus Eritematoso Discoide/diagnóstico , Lupus Eritematoso Discoide/patologíaRESUMEN
Central centrifugal cicatricial alopecia (CCCA) is the most common form of primary scarring alopecia in women of African descent, negatively impacting their quality of life. Treatment is often challenging, and we usually direct therapy to suppress and prevent the inflammation. However, factors affecting clinical outcomes are still unknown. To characterize medical features, concurrent medical conditions, hair care practices, and treatments used for patients with CCCA and assess their relationship with treatment outcomes. We analyzed data from a retrospective chart review of 100 patients diagnosed with CCCA who received treatment for at least one year. Treatment outcomes were compared with patient characteristics to determine any relationships. P-values were calculated using logistic regression and univariate analysis with 95% CI P < 0.05 was considered significant. After one year of treatment, 50% of patients were stable, 36% improved, and 14% worsened. Patients without a history of thyroid disease (P = 0.0422), using metformin for diabetes control (P = 0.0255), using hooded dryers (P = 0.0062), wearing natural hairstyles (P = 0.0103), and having no other physical signs besides cicatricial alopecia (P = 0.0228), had higher odds of improvement after treatment. Patients with scaling (P = 0.0095) or pustules (P = 0.0325) had higher odds of worsening. Patients with a history of thyroid disease (P = 0.0188), not using hooded dryers (0.0438), or not wearing natural hairstyles (P = 0.0098) had higher odds of remaining stable. Clinical characteristics, concurrent medical conditions, and hair care practices may affect clinical outcomes after treatment. With this information, providers can adjust proper therapies and evaluations for patients with Central centrifugal cicatricial alopecia.
Asunto(s)
Alopecia , Cicatriz , Dermatitis , Calidad de Vida , Femenino , Humanos , Alopecia/diagnóstico , Alopecia/etnología , Alopecia/etiología , Alopecia/terapia , Negro o Afroamericano , Cicatriz/etnología , Cicatriz/etiología , Cicatriz/terapia , Dermatitis/etnología , Dermatitis/etiología , Dermatitis/terapia , Cabello , Estudios Retrospectivos , Cuidados de la Piel/efectos adversos , Cuidados de la Piel/métodosRESUMEN
Platelet-rich plasma (PRP) offers anti-inflammatory and regenerative properties through angiogenesis, cell differentiation, and proliferation. Although studied in many dermatologic conditions, its efficacy is not well-understood. Our objective is to review the use and effectiveness of PRP for dermatologic conditions. A literature search was performed through PubMed and yielded 54 articles published between January 2000 and November 2021; articles written in English were reviewed. Intradermal injections were associated with increased hair density in androgenic alopecia. Successful treatment of inflammatory nail diseases with PRP has been reported. Improvement in psoriasis was described, but only two studies were available. PRP was associated with higher patient self-assessment scores of photoaging and fine lines. Treatment with PRP in melasma has been associated with improved subjective satisfaction, but not with objective measures of disease improvement. PRP can serve as a safe and potentially effective adjunct for hair loss, vitiligo, nonhealing wounds, photoaging, and acne scars. An important barrier to interpreting PRP research is lack of standardization of PRP preparation protocols, inconsistent clinical endpoints, and frequent combination treatments. However, PRP is relatively noninvasive, has a well-established safety profile, and patient satisfaction is often high as patients perceive great benefit from treatment with PRP.
Asunto(s)
Alopecia , Plasma Rico en Plaquetas , Humanos , Alopecia/terapia , Cicatriz/terapia , Satisfacción del Paciente , Inyecciones Intradérmicas , Resultado del TratamientoAsunto(s)
Tejido Adiposo/patología , Alopecia/tratamiento farmacológico , Edema/patología , Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Alopecia/patología , Humanos , Masculino , Persona de Mediana Edad , Ácido Micofenólico/uso terapéutico , Dermatosis del Cuero Cabelludo/patologíaRESUMEN
ABSTRACT: Primary cicatricial alopecias are inflammatory scalp conditions that may lead to permanent hair loss and severe alopecia. Frontal fibrosing alopecia is one of the most frequent etiologies of primary cicatricial alopecias. Hair transplant could be a therapeutic option.High-resolution ultrasound (US) is an imaging technique useful for evaluating scalp with adequate differentiation of the skin layers. Also, hair follicles are visualized.The objectives are present presurgical and posttransplant scalp US studies on hair transplant.Frontal fibrosing alopecia is a chronic entity that can progress to extensive irreversible alopecia. Hair transplant is a surgical option. On US, the hair follicles are visualized as thin hypoechoic lines. With Doppler color imaging, it is possible to evaluate vascularization. In this experience, we can observe the follicles of the compromised area before and after the hair transplant and the depth of the implanted follicles.In conclusion, US impresses as a promissory technique for the imaging of hair transplant. More experience is necessary for a better approach of these findings.